Breast Cancer ASCO 2023 Highlights - OncBrothers (Rohit and Rahul Gosain) with Dr. Stephanie Graff

Описание к видео Breast Cancer ASCO 2023 Highlights - OncBrothers (Rohit and Rahul Gosain) with Dr. Stephanie Graff

Discussing Breast Cancer ASCO 2023 Highlights, focusing on practice changing studies with Dr. Stephanie Graff, Director of Breast Oncology, Associate Professor of Medicine, Lifespan Cancer Institute, Brown University.

Covering three important studies:
- NATALEE Phase III study of ribociclib (RIBO) + endocrine therapy (ET) in HR+ patients
- SONIA challenging the need of first-line use for a CDK4/6 Inhibitor in HR+ advanced breast cancer patients
- X-7/7 trial evaluating fixed-dose capecitabine compared to standard dose capecitabine in metastatic breast cancer

#asco #2023 #breastcancer #oncbrothers #oncology #lifespan #brownuniversity

Website: http://www.oncbrothers.com/
Twitter:   / oncbrothers  

Contact us at [email protected]

Комментарии

Информация по комментариям в разработке